The earnings call reflects a mixed performance for Bioceres Crop Solutions. The company highlighted significant improvements in cash flow and the EPA approval of RinoTec, which positions them well for future opportunities. However, these positives were offset by a decline in revenues and gross profit due to seasonal factors and the absence of a major payment from Syngenta. Argentina's market challenges also weighed on performance, though positive developments in other geographies and segments offer a balanced outlook.

Company Guidance

During Bioceres Crop Solutions' fiscal third quarter 2025 earnings call, the company reported significant financial metrics that highlighted both challenges and achievements. The total revenue for the quarter was $60.6 million, down from $84 million the previous year, largely due to the prior year's accrual of a $16 million upfront payment from Syngenta. Despite this revenue dip, Bioceres achieved a notable $40 million year-over-year improvement in cash flow, which was attributed to strategic shifts in their seed business strategy and working capital management. The gross profit for the quarter was $24 million, compared to $42.6 million last year, with a decline in gross margin from 51% to 39% largely explained by the absence of the Syngenta payment. The adjusted EBITDA was $9 million, down from $21.1 million, reflecting these revenue and gross profit changes. The company's strong focus on cash flow led to a $23.3 million net cash generation from operating activities, a $40.7 million improvement compared to the previous year. This performance allowed for a cash position increase of nearly $10 million and a total debt reduction of $13 million, resulting in a leverage ratio slightly above 4.1. Bioceres also emphasized its strategic focus on transitioning to a more sustainable and productive agricultural model, with the EPA approval of RinoTec marking a crucial development in their portfolio of biological solutions for pest control and plant health.

Exceptional Cash Flow Performance

Reported a $40 million year-over-year improvement in cash flow, significantly reducing debt and improving cash position.

EPA Approval of RinoTec

Received long-awaited EPA approval of RinoTec, enabling a full suite of biological solutions for pest control and plant health across major markets.

Seed & Integrated Products Revenue Growth

Revenues in Seed & Integrated Products increased by 26%, primarily driven by accelerated sales of HB4 grain from existing inventory.

Improved Working Capital Management

Achieved a tangible $40.7 million improvement in net cash from operating activities due to efficient working capital management.

Positive Performance in U.S. and Mexico

U.S. and Mexico markets showed signs of recovery and delivered good growth during the quarter.

Bioceres Crop Solutions (BIOX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BIOX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Sep 09, 2025	2025 (Q4)	0.07 / -	-0.033	―	―	―
May 21, 2025	2025 (Q3)	-0.13 / -0.02	0.139	-115.11% (-0.16)
Feb 11, 2025	2025 (Q2)	0.10 / <0.01	0.019	-52.63% (-0.01)
Nov 12, 2024	2025 (Q1)	-0.02 / -0.08	-0.07	-20.00% (-0.01)
Sep 09, 2024	2024 (Q4)	0.23 / -0.03	-0.06	45.00% (+0.03)
May 13, 2024	2024 (Q3)	0.17 / 0.14	0.436	-68.12% (-0.30)
Feb 08, 2024	2024 (Q2)	0.09 / 0.02	-0.13	114.62% (+0.15)
Nov 13, 2023	2024 (Q1)	0.09 / -0.07	0.035	-300.00% (-0.11)
Sep 10, 2023	2023 (Q4)	0.02 / -0.06	-0.12	50.00% (+0.06)
May 10, 2023	2023 (Q3)	-0.03 / 0.44	-0.16	372.50% (+0.60)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BIOX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 21, 2025	$4.65	$4.45	-4.30%
Feb 11, 2025	$5.55	$4.78	-13.87%
Nov 12, 2024	$6.48	$6.66	+2.78%
Sep 09, 2024	$9.99	$8.65	-13.41%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bioceres Crop Solutions (BIOX) report earnings?

Bioceres Crop Solutions (BIOX) is schdueled to report earning on Sep 09, 2025, Before Open (Confirmed).

What is Bioceres Crop Solutions (BIOX) earnings time?

Bioceres Crop Solutions (BIOX) earnings time is at Sep 09, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BIOX EPS forecast?

BIOX EPS forecast for the fiscal quarter 2025 (Q4) is 0.07.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing